Henderson Group »

Evommune shares owned by Henderson Group

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Henderson Group from 13F filings

Historical chart of Henderson Group investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Henderson Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Henderson Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 897k 22.99

More positions owned by Henderson Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Astrazeneca Ord (AZN)
Mastercard Incorporated Cl A (MA)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)
Argenx Se Sponsored Adr (ARGX)
Kla Corp Com New (KLAC)

View all positions for Henderson Group

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
BlackRock
Kynam Capital Management

View all funds holding Evommune